All In MedTech

Device Trial Radar · NCT06460246

Pulse Oximeter Accuracy During Stable Hypoxia Plateaus

Last checked: Nov 20, 2026Latest source record: Aug 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Jun 25, 2024

Primary completion

Jun 27, 2024

Study completion Jul 31, 2024

Sponsor

Lead sponsor
Acurable Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jun 14, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This project aims to test the accuracy of pulse oximeters in the range of arterial HbO2 saturations from 100% down to 70%.

Conditions

  • Healthy

Interventions

  • Pulse OximeterDevice

    The subjects will have a 22-gauge catheter inserted in the radial artery to measure the oxygen saturation of arterial blood and also wear pulse oximeters.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance of the pulse oximeters against corresponding arterial blood oxygen saturation.Time frame: 1-4 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vital Signs Research Group, L.L.C.

    San Francisco, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.